Johnson & Johnson Price to Free Cash Flow Ratio 2006-2019 | JNJ
Historical price to free cash flow ratio values for Johnson & Johnson (JNJ) since 2006.
| Johnson & Johnson Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2019-08-16 |
131.36 |
|
7.09 |
| 2019-06-30 |
139.28 |
$18.54 |
7.51 |
| 2019-03-31 |
139.79 |
$17.76 |
7.87 |
| 2018-12-31 |
128.20 |
$17.68 |
7.25 |
| 2018-09-30 |
136.39 |
$16.86 |
8.09 |
| 2018-06-30 |
118.99 |
$16.53 |
7.20 |
| 2018-03-31 |
124.74 |
$15.97 |
7.81 |
| 2017-12-31 |
135.14 |
$15.75 |
8.58 |
| 2017-09-30 |
124.99 |
$14.63 |
8.54 |
| 2017-06-30 |
126.38 |
$13.55 |
9.33 |
| 2017-03-31 |
118.20 |
$12.95 |
9.13 |
| 2016-12-31 |
108.63 |
$12.65 |
8.59 |
| 2016-09-30 |
110.62 |
$13.58 |
8.15 |
| 2016-06-30 |
112.83 |
$14.67 |
7.69 |
| 2016-03-31 |
99.94 |
$15.44 |
6.47 |
| 2015-12-31 |
94.20 |
$15.74 |
5.99 |
| 2015-09-30 |
84.98 |
$15.63 |
5.44 |
| 2015-06-30 |
88.03 |
$16.36 |
5.38 |
| 2015-03-31 |
90.21 |
$16.41 |
5.50 |
| 2014-12-31 |
93.12 |
$16.70 |
5.58 |
| 2014-09-30 |
94.31 |
$14.81 |
6.37 |
| 2014-06-30 |
91.94 |
$13.02 |
7.06 |
| 2014-03-31 |
85.73 |
$12.16 |
7.05 |
| 2013-12-31 |
79.36 |
$11.63 |
6.83 |
| 2013-09-30 |
74.60 |
$11.63 |
6.41 |
| 2013-06-30 |
73.34 |
$11.66 |
6.29 |
| 2013-03-31 |
69.12 |
$11.92 |
5.80 |
| 2012-12-31 |
58.96 |
$12.25 |
4.81 |
| 2012-09-30 |
57.45 |
$11.87 |
4.84 |
| 2012-06-30 |
55.82 |
$11.45 |
4.88 |
| 2012-03-31 |
53.98 |
$10.99 |
4.91 |
| 2011-12-31 |
53.20 |
$10.75 |
4.95 |
| 2011-09-30 |
51.19 |
$11.37 |
4.50 |
| 2011-06-30 |
52.99 |
$11.95 |
4.43 |
| 2011-03-31 |
46.79 |
$12.45 |
3.76 |
| 2010-12-31 |
48.41 |
$12.95 |
3.74 |
| 2010-09-30 |
48.08 |
$12.89 |
3.73 |
| 2010-06-30 |
45.40 |
$12.27 |
3.70 |
| 2010-03-31 |
49.67 |
$11.73 |
4.23 |
| 2009-12-31 |
48.69 |
$11.38 |
4.28 |
| 2009-09-30 |
45.67 |
$10.70 |
4.27 |
| 2009-06-30 |
42.26 |
$10.41 |
4.06 |
| 2009-03-31 |
38.79 |
$10.29 |
3.77 |
| 2008-12-31 |
43.76 |
$10.40 |
4.21 |
| 2008-09-30 |
50.27 |
$10.23 |
4.91 |
| 2008-06-30 |
46.39 |
$10.26 |
4.52 |
| 2008-03-31 |
46.44 |
$10.54 |
4.41 |
| 2007-12-31 |
47.44 |
$10.80 |
4.39 |
| 2007-09-30 |
46.44 |
$10.58 |
4.39 |
| 2007-06-30 |
43.27 |
$10.17 |
4.25 |
| 2007-03-31 |
42.04 |
$9.77 |
4.30 |
| 2006-12-31 |
45.79 |
$9.54 |
4.80 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$346.681B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
